Sanofi's reversible BTK inhibitor rilzabrutinib has gained the US Food and Drug Administration’s (FDA) orphan drug designation.

and warm autoimmune haemolytic anaemia (wAIHA). IgG4-RD is a chronic fibro-inflammatory condition that can result in organ damage and sometimes fatal outcomes, and wAIHA is a life-threatening ...

After dropping the FNAIT therapy, Rallybio will prioritise another candidate that is being investigated in complement-driven ...

MG-ADL (Myasthenia Gravis - Activities of Daily Living) provides a rapid clinical assessment of the patient's recall of symptoms impacting activities of daily living, with a total score range of 0 to ...

A key phase 3 readout in immune thrombocytopenia is due later this year, along with phase 2 results in asthma, IgG4-related disease, and warm autoimmune haemolytic anaemia, and phase 3 testing in ...

which is in a phase 3 trial as a treatment for IgG4-related disease (IgG4-RD), phase 2/3 in warm autoimmune haemolytic anaemia (wAIHA), and phase 2 in multiple sclerosis (MS) and systemic lupus ...

Autoimmune haemolytic anaemia (AIHA) is a rare, heterogeneous condition that poses diagnostic challenges, especially in direct antiglobulin test (DAT)-negative cases, where the absence of detectable ...

Choose from Haemolytic stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...